ArticlePloS one2025
Candidate orphan genes: Reassessing uniqueness.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Orphan genes lack recognizable homologues outside a given taxonomic unit; thus, they have uncertain evolutionary origins. This presents a profound challenge to traditional models of gene evolution. Their presence has fueled ongoing debate, and they have long been implicated in driving lineage-specific traits in medicine and evolutionary biology. These genes are often linked to species-specific traits and pathogenic mechanisms, including virulence and environmental adaptation, and their study provides critical insights into the origins and evolution of novel genes. Intrigued by their enigmatic nature, we re-analyzed a comprehensive 2023 dataset of orphan genes compiled from over 80,000 bacterial species. Using homology-based analyses, we reassessed the taxonomic distribution of each gene across a broader genomic landscape. Many "orphan genes" identified in 2023 now align with homologs in other bacterial taxa (as of 2025), demonstrating that limited database sampling had previously inflated the number of genes. This reassessment revealed an approximately 81% decrease in the number of orphan genes within just two years. These results challenged the long-held view that bacterial species truly harbor large numbers of orphan genes, instead demonstrating that their prevalence has been overestimated. To better reflect these findings, we propose that orphan genes be annotated using descriptors such as 'candidate' or 'putative', which more accurately convey the provisional and potentially temporary nature of their apparent uniqueness. Although our analysis greatly reduced false-positive classifications, it cannot determine whether a given candidate truly encodes a functional gene or is an artifact of bioinformatic analysis. To prioritize the most promising targets for biochemical or genetic validation, we applied additional computational filters and identified a subset of candidates most likely to encode bona fide proteins. This study redefines current understanding of orphan gene prevalence, establishes that such genes should be annotated with descriptors such as candidate or putative, much like we label "candidate bacterial species," and provides a refined, high-confidence dataset for future in vitro and in vivo investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.